Amitant-IV Injection

Amitant-IV Injection is a prescription medicine used to prevent nausea and vomiting caused by chemotherapy.

Amitant-IV Injection is given under the supervision of healthcare professional. Moreover, it is better to take it at a fixed time and you should not stop taking this medication suddenly without talking to your doctor. In case you have missed a dose than it is better to take it as soon as you remember it and finish the full course of treatment even if you feel better. Your doctor may advice for regular monitoring of liver function test while taking this medicine.It has side effects like fatigue, headache, loss of appetite, constipation and hiccups. Dizziness and sleepiness may also occur as a side effect, so do not drive or do anything that requires mental focus until you know how this medicine affects you.

Nausea and vomiting due to chemotherapy

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Amitant-IV Injection is an antiemetic medication. It works by blocking the action of a chemical messenger (neurokinin) in the brain that may cause nausea and vomiting during anti-cancer treatment (chemotherapy).

If you miss a dose of Amitant-IV Injection, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Amitant-IV Injection is given as a drip into the vein under the supervision of a doctor.

It makes you feel dizzy or drowsy. Do not drive until you know how this medicine affects you.

You will be monitored for liver functioning regularly while taking this medication.

Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.

Information not available at the moment. Please check back later.

In Nausea and vomiting due to chemotherapy

Amitant-IV Injection blocks the action of chemicals in the body that can make you feel or be sick. It is often used to prevent nausea and vomiting that may be caused due to some medicines or cancer treatment. This medicine helps you recover more comfortably from cancer treatments such as radiation therapy or chemotherapy. It is also effective at preventing nausea and vomiting after an operation (in adults only). It is given as an injection by a doctor and should not be self-administered.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Constipation

Decreased appetite

Fatigue

Indigestion

Hiccup

Headache

Alcohol:UNSAFE

It is unsafe to consume alcohol with Amitant-IV Injection.

Pregnancy:SAFE IF PRESCRIBED

Amitant-IV Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding:CONSULT YOUR DOCTOR

Amitant-IV Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving:UNSAFE

Amitant-IV Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney:SAFE IF PRESCRIBED

Amitant-IV Injection is safe to use in patients with kidney disease. No dose adjustment of Amitant-IV Injection is recommended.

Liver:CAUTION

Amitant-IV Injection should be used with caution in patients with severe liver disease. Dose adjustment of Amitant-IV Injection may be needed. Please consult your doctor.No dose adjustment is recommended in patients with moderate to severe liver disease.

McQuaid KR. Drugs Used in the Treatment of Gastrointestinal Diseases. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 1086.

Fosaprepitant dimeglumine. Hoddesdon, Hertfordshire: Merck Sharp & Dohme Limited; 2008 . Availale from: view

Fosaprepitant. Highway, Greenville, NC: DSM Pharmaceuticals; 2008. view

Central Drugs Standard Control Organisation . view